These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16952158)

  • 1. Lack of neuropeptide Y attenuates the somatic signs of opiate withdrawal.
    Olson VG; Griner NB; Heusner CL; Palmiter RD
    Synapse; 2006 Dec; 60(7):553-6. PubMed ID: 16952158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditioned place preference associates with the mRNA expression of diazepam binding inhibitor in brain regions of the addicted rat during withdrawal.
    Liu X; Li Y; Zhou L; Chen H; Su Z; Hao W
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):47-54. PubMed ID: 15950760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice.
    Papaleo F; Contarino A
    Behav Brain Res; 2006 Jun; 170(1):110-8. PubMed ID: 16580078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat.
    Jones KL; Barr GA
    Synapse; 2001 Feb; 39(2):139-51. PubMed ID: 11180501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal.
    Papaleo F; Ghozland S; Ingallinesi M; Roberts AJ; Koob GF; Contarino A
    Neuropsychopharmacology; 2008 Nov; 33(12):2878-87. PubMed ID: 18288089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10.
    Laurent P; Becker JA; Valverde O; Ledent C; de Kerchove d'Exaerde A; Schiffmann SN; Maldonado R; Vassart G; Parmentier M
    Nat Neurosci; 2005 Dec; 8(12):1735-41. PubMed ID: 16299503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors.
    Woldbye DP; Klemp K; Madsen TM
    J Pharmacol Exp Ther; 1998 Feb; 284(2):633-6. PubMed ID: 9454808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve.
    Sora I; Elmer G; Funada M; Pieper J; Li XF; Hall FS; Uhl GR
    Neuropsychopharmacology; 2001 Jul; 25(1):41-54. PubMed ID: 11377918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barium potentiates the conditioned aversion to, but not the somatic signs of, morphine withdrawal in mice.
    Sato M; Wada K; Funada M
    Eur J Pharmacol; 2005 Sep; 519(3):215-22. PubMed ID: 16122731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
    Guillem K; Vouillac C; Koob GF; Cador M; Stinus L
    Biol Psychiatry; 2008 Jan; 63(2):158-63. PubMed ID: 17643399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine release inhibitor CGS 10746B blocks conditioned physical signs of morphine withdrawal.
    Rodríguez-Arias M; Aguilar MA; Miñarro J
    Addict Biol; 2003 Jun; 8(2):167-72. PubMed ID: 12850775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion.
    Gracy KN; Dankiewicz LA; Koob GF
    Neuropsychopharmacology; 2001 Feb; 24(2):152-60. PubMed ID: 11120397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal.
    Papaleo F; Kitchener P; Contarino A
    Neuron; 2007 Feb; 53(4):577-89. PubMed ID: 17296558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate dependence induces network state shifts in the limbic system.
    Dejean C; Boraud T; Le Moine C
    Neurobiol Dis; 2013 Nov; 59():220-9. PubMed ID: 23911767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral pharmacology of narcotic antagonists.
    Mello NK
    NIDA Res Monogr; 1978; (19):126-41. PubMed ID: 218104
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of apoptosis in the mouse brain after morphine treatments and morphine withdrawal.
    Emeterio EP; Tramullas M; Hurlé MA
    J Neurosci Res; 2006 May; 83(7):1352-61. PubMed ID: 16496378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-treatment of dextromethorphan reverses morphine effect on conditioned place preference in rats.
    Lue WM; Huang EY; Yang SN; Wong CS; Tao PL
    Synapse; 2007 Jun; 61(6):420-8. PubMed ID: 17372963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice.
    Salmon AM; Damaj MI; Marubio LM; Epping-Jordan MP; Merlo-Pich E; Changeux JP
    Nat Neurosci; 2001 Apr; 4(4):357-8. PubMed ID: 11276224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.